BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

96 related articles for article (PubMed ID: 1633192)

  • 1. Characterisation of a tryptic peptide from human placental ribonuclease inhibitor which inhibits ribonuclease activity.
    Crevel-Thieffry I; Cotterill S; Schuller E
    Biochim Biophys Acta; 1992 Jul; 1122(1):107-12. PubMed ID: 1633192
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Primary structure of human placental ribonuclease inhibitor.
    Lee FS; Fox EA; Zhou HM; Strydom DJ; Vallee BL
    Biochemistry; 1988 Nov; 27(23):8545-53. PubMed ID: 3219362
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Interaction of human placental ribonuclease with placental ribonuclease inhibitor.
    Shapiro R; Vallee BL
    Biochemistry; 1991 Feb; 30(8):2246-55. PubMed ID: 1998683
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The ribonuclease activity of nucleolar protein B23.
    Herrera JE; Savkur R; Olson MO
    Nucleic Acids Res; 1995 Oct; 23(19):3974-9. PubMed ID: 7479045
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Molecular recognition of human angiogenin by placental ribonuclease inhibitor--an X-ray crystallographic study at 2.0 A resolution.
    Papageorgiou AC; Shapiro R; Acharya KR
    EMBO J; 1997 Sep; 16(17):5162-77. PubMed ID: 9311977
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Human placental ribonuclease inhibitor abolishes both angiogenic and ribonucleolytic activities of angiogenin.
    Shapiro R; Vallee BL
    Proc Natl Acad Sci U S A; 1987 Apr; 84(8):2238-41. PubMed ID: 3470787
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Modular mutagenesis of human placental ribonuclease inhibitor, a protein with leucine-rich repeats.
    Lee FS; Vallee BL
    Proc Natl Acad Sci U S A; 1990 Mar; 87(5):1879-83. PubMed ID: 2408043
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Structure and action of mammalian ribonuclease (angiogenin) inhibitor.
    Lee FS; Vallee BL
    Prog Nucleic Acid Res Mol Biol; 1993; 44():1-30. PubMed ID: 8434120
    [No Abstract]   [Full Text] [Related]  

  • 9. Tryptophan fluorescence as a probe of placental ribonuclease inhibitor binding to angiogenin.
    Lee FS; Auld DS; Vallee BL
    Biochemistry; 1989 Jan; 28(1):219-24. PubMed ID: 2706245
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Expression of human placental ribonuclease inhibitor in Escherichia coli.
    Lee FS; Vallee BL
    Biochem Biophys Res Commun; 1989 Apr; 160(1):115-20. PubMed ID: 2653313
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Binding of placental ribonuclease inhibitor to the active site of angiogenin.
    Lee FS; Vallee BL
    Biochemistry; 1989 Apr; 28(8):3556-61. PubMed ID: 2742853
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cytoplasmic ribonuclease inhibitor.
    Shapiro R
    Methods Enzymol; 2001; 341():611-28. PubMed ID: 11582809
    [No Abstract]   [Full Text] [Related]  

  • 13. Ribonuclease inhibitor from human placenta: rapid purification and assay.
    Blackburn P
    J Biol Chem; 1979 Dec; 254(24):12484-7. PubMed ID: 500726
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Residues 287-301 of human ribonuclease inhibitor do not affect ribonuclease activity and inhibitor binding; a reply.
    Fominaya J; Neumann U; Hofsteenge J
    Biochim Biophys Acta; 1993 Nov; 1203(1):168-70. PubMed ID: 8218387
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Kinetic characterization of two active mutants of placental ribonuclease inhibitor that lack internal repeats.
    Lee FS; Vallee BL
    Biochemistry; 1990 Jul; 29(28):6633-8. PubMed ID: 2397204
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Inhibition of human pancreatic ribonuclease by the human ribonuclease inhibitor protein.
    Johnson RJ; McCoy JG; Bingman CA; Phillips GN; Raines RT
    J Mol Biol; 2007 Apr; 368(2):434-49. PubMed ID: 17350650
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Purification of mammalian ribonuclease using immobilized human ribonuclease inhibitor.
    Nadano D; Yasuda T; Takeshita H; Sawazaki K; Kishi K
    Protein Expr Purif; 1996 Mar; 7(2):167-72. PubMed ID: 8812855
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Angiogenin single-chain immunofusions: influence of peptide linkers and spacers between fusion protein domains.
    Newton DL; Xue Y; Olson KA; Fett JW; Rybak SM
    Biochemistry; 1996 Jan; 35(2):545-53. PubMed ID: 8555226
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Tight-binding inhibition of angiogenin and ribonuclease A by placental ribonuclease inhibitor.
    Lee FS; Shapiro R; Vallee BL
    Biochemistry; 1989 Jan; 28(1):225-30. PubMed ID: 2706246
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Identification of lysine residues in the binding domain of ribonuclease A for the RNase inhibitor from human placenta.
    Blackburn P; Gavilanes JG
    J Biol Chem; 1982 Jan; 257(1):316-21. PubMed ID: 6273432
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.